Us Bancorp \De\ First Wave Bio Pharma, Inc. Transaction History

Us Bancorp \De\

  • $77.3 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022
BUY
$1.3 - $7.65 $221 - $1,300
170 New
170 $0

Others Institutions Holding FWBI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About First Wave BioPharma, Inc.

FWBI Quotes by TradingView
  • Ticker FWBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,562,010
  • Market Cap $2.54M
  • Description
  • First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic ...
More about FWBI
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email